These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 22582547)

  • 21. Evidence for association of the GLI2 gene with tardive dyskinesia in patients with chronic schizophrenia.
    Greenbaum L; Alkelai A; Rigbi A; Kohn Y; Lerer B
    Mov Disord; 2010 Dec; 25(16):2809-17. PubMed ID: 20939080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology and characteristics of emergency departments visits by US adults with psychiatric disorder and antipsychotic mention from 2000 to 2004.
    Sankaranarayanan J; Puumala SE
    Curr Med Res Opin; 2007 Jun; 23(6):1375-85. PubMed ID: 17594776
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and costs of cardiometabolic conditions in patients with schizophrenia treated with antipsychotic medications.
    Jerrell JM; McIntyre RS; Tripathi A
    Clin Schizophr Relat Psychoses; 2010 Oct; 4(3):161-8. PubMed ID: 20880826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of diabetes mellitus in chronic schizophrenic inpatients in relation to long-term antipsychotic treatment.
    Cohen D; Dekker JJ; Peen J; Gispen-de Wied CC
    Eur Neuropsychopharmacol; 2006 Apr; 16(3):187-94. PubMed ID: 16263247
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Adverse effects of antipsychotics and quality of life].
    Mínguez Martín L; González Pablos E; Alonso del Teso F; Sanguino Andrés RM; García Alonso Y
    Actas Esp Psiquiatr; 2005; 33(1):1-6. PubMed ID: 15704024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychopharmacotherapy and remission of patients with schizophrenia.
    Degmecić D; Pozgain I; Filaković P; Dodig-Curković K; Mihanović M
    Coll Antropol; 2009 Jun; 33(2):547-51. PubMed ID: 19662777
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study.
    Braus DF; Ende G; Weber-Fahr W; Demirakca T; Henn FA
    Pharmacopsychiatry; 2001 Nov; 34(6):251-3. PubMed ID: 11778146
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of switching from conventional antipsychotics to risperidone in Japanese patients with chronic schizophrenia.
    Nakanishi S; Kunugi H; Murray RM; Nojima S; Ogawa T; Takahashi T
    Psychiatry Clin Neurosci; 2006 Dec; 60(6):751-7. PubMed ID: 17109710
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of switching to atypical antipsychotics on memory in patients with chronic schizophrenia.
    Mori K; Nagao M; Yamashita H; Morinobu S; Yamawaki S
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 Jul; 28(4):659-65. PubMed ID: 15276691
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum BDNF levels and weight gain in schizophrenic patients on long-term treatment with antipsychotics.
    Zhang XY; Tan YL; Zhou DF; Cao LY; Wu GY; Xu Q; Shen Y; Haile CN; Kosten TA; Kosten TR
    J Psychiatr Res; 2007 Dec; 41(12):997-1004. PubMed ID: 17095017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore.
    Shafie S; Lee SP; Ong SBC; Wang P; Seow E; Ong HL; Chong SA; Subramaniam M
    Singapore Med J; 2018 Sep; 59(9):465-471. PubMed ID: 29430576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of dyslipidaemia with antipsychotic drug treatment in Chinese inpatients with mental illness: a hospital-based cohort study.
    Ma Q; Yang F; Ma B; Jing W; Liu J; Guo M; Li J; Wang Z; Liu M
    BMJ Open; 2021 Jan; 11(1):e043259. PubMed ID: 33518524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of association between antipsychotics and hyponatremia in chronic schizophrenia.
    Jessani M; Montgomery J; Fedde JD; Josiassen RC
    Schizophr Res; 2006 Apr; 83(2-3):307-9. PubMed ID: 16504483
    [No Abstract]   [Full Text] [Related]  

  • 34. Pharmacogenomics of sterol synthesis and statin use in schizophrenia subjects treated with antipsychotics.
    Vassas TJ; Burghardt KJ; Ellingrod VL
    Pharmacogenomics; 2014 Jan; 15(1):61-7. PubMed ID: 24329191
    [TBL] [Abstract][Full Text] [Related]  

  • 35. First-episode affective psychosis and lipid monitoring: survival analysis of the first abnormal lipid test.
    Archie S; Zangeneh-Kazemi A; Akhtar-Danesh N
    Early Interv Psychiatry; 2015 Dec; 9(6):507-11. PubMed ID: 25130568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical Assessment of Cardiovascular Risk Associated with the Duration of Antipsychotic Therapy in Patients with Schizophrenia.
    Akande AA; Adelekan A; Abdulazeez IM
    West Afr J Med; 2021 Dec; 38(12):1156-1161. PubMed ID: 35032384
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Atypical antipsychotics.
    Kapur S; Remington G
    BMJ; 2000 Dec; 321(7273):1360-1. PubMed ID: 11099266
    [No Abstract]   [Full Text] [Related]  

  • 38. Scrutinizing the increased mortality risk associated with the use of typical oral antipsychotics.
    Andrade C; Suhas S
    Schizophr Res; 2022 Feb; 240():204. PubMed ID: 35032905
    [No Abstract]   [Full Text] [Related]  

  • 39. Comment on: Prevalence and correlates of diabetes mellitus and dyslipidaemia in a long-stay inpatient schizophrenia population in Singapore.
    Afifi M
    Singapore Med J; 2019 Feb; 60(2):104. PubMed ID: 30843074
    [No Abstract]   [Full Text] [Related]  

  • 40. Comorbid dyslipidaemia and diabetes, but not antipsychotic use, is associated with unexplained sudden death among psychiatric patients.
    Reilly J
    Evid Based Ment Health; 2012 May; 15(2):30. PubMed ID: 22228802
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.